Boothbay Fund Management’s Eli Lilly LLY Stock Holding History

Boothbay Fund Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,400	Closed	-$5.79M	–	1794
2024 Q2	$5.79M	Buy	+6,400	New	+$5.12M	0.14%	187
2023 Q2	–	Sell	-21,400	Closed	-$7.35M	–	2073
2023 Q1	$7.35M	Buy	21,400 +7,200	+51%	+$2.43M	0.15%	139
2022 Q4	$5.19M	Sell	14,200 -57,600	-80%	-$20.4M	0.12%	223
2022 Q3	$23.2M	Buy	71,800 +70,700	+6,427%	+$22.4M	0.58%	7
2022 Q2	$357K	Sell	1,100 -1,700	-61%	-$510K	0.01%	1358
2022 Q1	$802K	Buy	+2,800	New	+$721K	0.02%	1033
2021 Q4	–	Sell	-9,900	Closed	-$2.29M	–	2067
2021 Q3	$2.29M	Buy	+9,900	New	+$2.44M	0.06%	398
2021 Q1	–	Sell	-104	Closed	-$1.76M	–	1673
2020 Q4	$1.76M	Buy	+104	New	+$15.5K	0.07%	304

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Boothbay Fund Management's LLY Position: Q1 2026 in Review

Boothbay Fund Management reduced its Eli Lilly (LLY) stake by 62% in Q1 2026, selling an estimated $4.27M and leaving 2,529 shares worth $2.33M. The position accounts for 0.03% of the portfolio, ranked #556.

Boothbay Fund Management first reported a position in LLY in Q3 2015 and has held it in 21 quarters since. The position peaked at $14.5M in Q1 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Boothbay Fund Management held 2,529 shares of Eli Lilly worth $2.33M as of Q1 2026.
Boothbay Fund Management sold 4,214 Eli Lilly shares in Q1 2026, an estimated $4.27M.
Eli Lilly made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #556 holding.
Boothbay Fund Management first reported a position in Eli Lilly in Q3 2015 and has held it in 21 quarters since.
Boothbay Fund Management's Eli Lilly position peaked at $14.5M in Q1 2023.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.